A double-blind, placebo-controlled comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal allergic rhinitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 11, 1999, Pages 1173-1180

  Ortolani, C ^j   Foresi, Antonio ^a   Di Lorenzo, G ^b   Bagnato, G ^c   Bonifazi, F ^j   Crimi, N ^d   Emmi, L ^e   Prandini, M ^f   Senna, G E ^g   Tursi, A ^h   Mirone, C ^j   Leone, C ^a   Fina, P ⁱ   Testi, R ⁱ  

^a Servizio di Pneumologia e Fisiopatologia Respiratoria   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d Ospodale Tommaselli   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f Ospedale Armanni   (Italy)

^g MAGGIORE HOSPITAL   (Italy)

^h Ospedale Civile   (Italy)

ⁱ GSK   (Italy)

^j NONE

more..

Author keywords

Fluticasone propionate; Levocabastine; Seasonal allergic rhinitis

Indexed keywords

FLUTICASONE PROPIONATE; LEVOCABASTINE; PLACEBO;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE OBSTRUCTION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SCORING SYSTEM; SNEEZING; SYMPTOMATOLOGY;

ADULT; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; DOUBLE-BLIND METHOD; EOSINOPHILIA; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYDROCORTISONE; MALE; PIPERIDINES; RHINITIS, ALLERGIC, SEASONAL;

EID: 0032731344     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00200.x     Document Type: Article

References (26)

1. 1. Naclerio RM. Allergic rhinitis. N Engl J Med 1991;325:860-869.
2. 2. International Rhinitis Management Working Group. International Consensus Report on the Diagnosis and Management of Rhinitis. Allergy 1994;49 Suppl 19:1-34.
3. 3. Lemanske RF Jr. A review of the current guidelines for allergic rhinitis and asthma. J Allergy Clin Immunol 1998;101:S392-S396.
4. 4. Davies RJ, Bagnall AC, McCabe RN, Calderon MA, Wang JH. Antihistamines: topical vs oral administration. Clin Exp Allergy 1996;26 Suppl 3:11-17.
5. 5. Noble S, McTavish D. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis. Drugs 1995;50:1032-1049.
6. 6. van de Heyning PH, van Haesendonck J, Creten W, Rombaut N. Effect of topical levocabastine on allergic and non-allergic perennial rhinitis. A double-blind study, levocabastine vs. placebo, followed by an open, prospective, single-blind study on beclomethasone. Allergy 1988;43:386-391.
7. 7. Dahl R, Pedersen B, Larsen B. Intranasal levocabastine for the treatment of seasonal allergic rhinitis: a multicentre, double-blind, placebo-controlled trial. Rhinology 1995;33:121-125.
8. 8. Palma-Carlos AG, Chieira C, Conde TA, Cordeiro JA. Double-blind comparison of levocabastine nasal spray with sodium cromoglycate nasal spray in the treatment of seasonal allergic rhinitis. Ann Allergy 1991;67:394-398.
9. 9. Bahmer FA, Ruprecht KW. Safety and efficacy of topical levocabastine compared with oral terfenadine. Ann Allergy 1994;72:429-434.
10. 10. Meltzer EO, Orgel HA, Bronsky EA, et al. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology. J Allergy Clin Immunol 1990;86:221-230.
11. 11. Nathan RA, Bronsky EA, Fireman P, et al. Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Ann Allergy 1991;67:332-338.
12. 12. Bousquet J, Chanal I, Alquie MC, et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study. Allergy 1993;48:327-333.
13. 13. Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R, Once daily intranasal fluticasone propionate (200 μg) reduces nasal symptoms and inflammation hut also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996;98:274-282.
14. 14. van Bavel J, Findlay SR, Hampel FC Jr, Martin BG, Ratner P, Field E. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med 1994;154:2699-2704.
15. 15. Darnell R, Pécoud A, Richards DH. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen. Clin Exp Allergy 1994;24:1144-1150.
16. 16. Bronsky EA, Dockhorn RJ, Meltzer EO, et al. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:915-921.
17. 17. Jordana G, Dolovich J, Briscoe MP, et al. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:588-595.
18. 18. Gehanno P, Desfougeres JL. Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis. Allergy 1997;52:445-450.
19. 19. Alvarado-Valdes CA, Blomgren J, Weiler D, et al. The effect of fluticasone propionate aqueous nasal spray on eosinophils and cytokines in nasal secretions of patients with ragweed allergic rhinitis. Clin Ther 1997;19:273-281.
20. 20. Pelucchi A, Chiapparino A, Mastropasqua B, Marazzini L, Hernandez A, Foresi A. Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollens. J Allergy Clin Immunol 1995;95:515-523.
21. 21. Roquat A, Ihre E, van Hage-Hamsten M, Hallden G, Zetterström O. Allergen-induced inflammation in the mise: a comparison of acute and repeated low-dose allergen exposure. Allergy 1996;51:42-48.
22. 22. Buscaglia S, Paolieri F, Catrullo A, et al. Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro. Clin Exp Allergy 1996;26:1188-1196.
23. 23. de Graaf-in 't Veld T, Garrelds IM, van Toorenenbergen AW, Mulder PG, Gerth van Wijk R, Boegheim JP. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis. Ann Allergy Asthma Immunol 1995;75:261-266.
24. 24. Bachert C, Wagenmann M, Vossen-Holzenkamp S. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge. Rhinology 1996;34:140-143.
25. 25. Svensson C, Andersson M, Greiff L, Blychert LO, Persson CG. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis. Allergy 1998;53:367-374.
26. 26. Vargas R, Dockhorn RJ, Findlay SR, Korenblat PE, Field EA, Kral KM. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol 1998;102:191-197.